News

November 30, 2015November 30, 2015

Rheumatoid Arthritis Women’s Fertility May Improve by a Preconception Treatment Strategy

News

When rheumatoid arthritis (RA) is diagnosed in women of child-bearing age, it can compromise fertility and prevent conception, with several factors contributing to the prolonged time to pregnancy (TTP) and fewer ... Read more

November 25, 2015November 25, 2015

Short-Term Data Predicts Long-Term Clinical Efficacy in Rheumatoid Arthritis Clinical Trials

News

Researchers have created a model of predictability of long-term efficacy using 3-month efficacy data in rheumatoid arthritis treatment. Moreover, researchers also show how short-term data can inform the probability of clinical ... Read more

November 20, 2015November 20, 2015

Autoimmune Research Laboratory at UCSF to Be Established After Receiving Parker Foundation Gift

News

A new research laboratory will be established at the UC San Francisco Diabetes Center thanks to a $10 million gift granted by The Parker Foundation. The facility will be focused on ... Read more

November 18, 2015November 18, 2015

RA Patients Taking Tofacitinib Can Be Vaccinated for Shingles, Study Finds

News

Older rheumatoid arthritis (RA) patients being treated with tofacitinib responded well when given a live virus vaccine to prevent shingles, experiencing no clinical complications after vaccination, a new study reports. The findings are ... Read more

November 16, 2015November 16, 2015

Boehringer Enrolls RA Patients for Phase 3 Trial of Adalimumab Equivalent

News

Boehringer Ingelheim, one of the largest producers of biologic medicines in the world, recently announced that it has completed enrolling patients for its pivotal Phase 3 clinical trial (NCT02137226) evaluating BI-695501, a biosimilar drug ... Read more

November 11, 2015November 11, 2015

Phase 3 Rheumatoid Arthritis Study Raises Possibility of New Drug Treatment

News

Eli Lilly and Incyte Corporation recently presented comprehensive results from a pivotal Phase 3 clinical trial, RA-BEAM, evaluating baricitinib in the treatment of rheumatoid arthritis (RA). The data were presented during ... Read more

November 9, 2015November 9, 2015

Potential Rheumatoid Arthritis Vaccine Gets Boost from NIH

News

Vienna, Virginia-based CEL-SCI Corporation, a biopharmaceutical company focused on research and development directed at disease treatments that utilize the immune system’s natural defense processes, announced that its investigational LEAPS rheumatoid ... Read more

November 7, 2015November 13, 2015

Rheumatoid Arthritis Drug Eases Inflammation in Early Trial

News

Compugen Ltd., a leading drug discovery company and first-in-class biologics developer, recently disclosed data from its translational trial supporting the use of CGEN-15001 for the potential treatment of patients with a diagnosis of ... Read more

November 6, 2015November 9, 2015

Novel Inhibitor for Autoimmune Diseases Moving to Phase 2 Trial

News

Hutchison MediPharma Limited (HMP) released the outcome of its Phase I clinical trial of HMPL-523. The first-in-human study was a dose-escalating trial to assess the safety, tolerability, and side effects of single ... Read more

November 4, 2015November 4, 2015

In RA Pilot Study, Atacicept in Combination with Rituximab Shows No Clinical Benefits

News

Results from a recently pilot study published in the journal Arthritis & Rheumatology showed that in patients with rheumatoid arthritis (RA), atacicept combined with rituximab had no new safety issues but ... Read more